SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-060355
Filing Date
2020-11-24
Accepted
2020-11-24 19:06:53
Documents
2
Period of Report
2020-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1612
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3432
  Complete submission text file 0001209191-20-060355.txt   6575
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Issuer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EDDEVA B920 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address
Forster Eliot (Reporting) CIK: 0001831558 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37718 | Film No.: 201346244